In one clinical trial , diarrhea occurred in 13% of patients taking 0.5 mg of Ozempic, 11% in those taking 1 mg, and 2% in the placebo group
FGF21 agonists: an emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
An inability to pass gas or stool is a symptom of possible bowel obstruction
Translating Results to Pounds For men at various starting weights, using the 15% average: Starting at 220 pounds: Average expected loss: 33 pounds End weight: 187 pounds High responder (20%+): Could reach 176 pounds or lower Starting at 250 pounds: Average expected loss: 37-38 pounds End weight: 212-213 pounds High responder: Could reach 200 pounds or lower Starting at 280 pounds: Average expected loss: 42 pounds End weight: 238 pounds High responder: Could reach 224 pounds or lower Starting at 300 pounds: Average expected loss: 45 pounds End weight: 255 pounds High responder: Could reach 240 pounds or lower These are approximations based on average results
However, if symptoms remain severe, interfere with daily activities, or prevent you from eating and drinking normally, its important to contact your healthcare provider rather than simply stopping the medication